Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?

Mov Disord. 2013 Dec;28(14):1915-9. doi: 10.1002/mds.25735. Epub 2013 Nov 15.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Deep Brain Stimulation*
  • Disruptive, Impulse Control, and Conduct Disorders / etiology*
  • Disruptive, Impulse Control, and Conduct Disorders / therapy*
  • Humans
  • Intestines / drug effects
  • Intestines / physiology
  • Levodopa / adverse effects*
  • Parkinson Disease / complications
  • Parkinson Disease / therapy

Substances

  • Antiparkinson Agents
  • Levodopa